Highlights
- •What is the primary question addressed by this study? – This review explores proactive, patient-centered strategies to promote psychosocial adaptation in Parkinson's disease
- •What is the main finding of this study? – Psychosocial adaptation strategies have improved quality of life in many chronic diseases and can be adapted for Parkinson's disease
- •What is the meaning of the finding? – To improve quality of life in Parkinson's disease we propose a “Wellness Prescription”, a proactive strategy to adaptively cope with the progression of disease
Abstract
The mid- to late-stages of Parkinson's disease (PD) bring increasing disability that
may challenge independence and lower quality of life. Many people with PD struggle
to remain hopeful and cope with an uncertain future due to the progression of the
disease. Although disability in PD is due chiefly to motor impairment, nonmotor symptoms
and psychosocial distress are also major contributors that are amenable to treatment.
Interventions that address nonmotor symptoms and psychosocial distress can improve
daily function and quality of life even as motor function worsens with disease progression.
This manuscript proposes a patient-centered, proactive strategy to promote psychosocial
adaptation to decrease the impact of motor, nonmotor, and psychosocial distress on
quality of life and function in people with PD.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Geriatric PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Quality of Life and Psychosocial Adaptation to Chronic Illness and Disability:Preliminary Analysis of a Conceptual and Theoretical Synthesis.Rehabilitation Counseling Bulletin. 2005; 48: 219-231
- Psychosocial Adaptation to Chronic Illness and Disability:A Conceptual Framework.Rehabilitation Counseling Bulletin. 2001; 44: 151-160
- Psychosocial adaptation to chronic illness and disability.Aspen, 1997
- Psychological adjustment has a greater effect on health-related quality of life than on severity of disease in Parkinson's disease.Mov Disord. 2006; 21: 761-766
- Predictors of health-related quality of life in Parkinson's disease.Parkinsonism & Related Disorders. 2019; 65: 86-90
- Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.Mov Disord. 2001; 16: 448-458
- Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.Mov Disord. 2007; 22: 2409-2417
- Levodopa-induced dyskinesias.Mov Disord. 2007; 22: 1379-1389
- Levodopa-dyskinesia incidence by age of Parkinson's disease onset.Mov Disord. 2005; 20: 342-344
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.Ann Neurol. 2010; 68: 18-27
- Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.J Neural Transm (Vienna). 2018; 125: 1109-1117
- The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia.Neurosci Lett. 2013; 556: 109-112
- Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.Mov Disord. 2005; 20: S11-S16
- Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study.Parkinsonism Relat Disord. 2012; 18: 1084-1088
- Nonmotor fluctuations in Parkinson's disease: clinical spectrum and classification.J Neurol Sci. 2010; 289: 89-92
- Nonmotor fluctuations in Parkinson's disease: frequent and disabling.Neurology. 2002; 59: 408-413
- The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?.Parkinsonism Relat Disord. 2018; 51: 9-16
- Predictors of motor complications in early Parkinson's disease: A prospective cohort study.Mov Disord. 2019; 34: 1174-1183
- [Incidence and determinants of levodopa-induced dyskinesia in a retrospective cohort of Mexican patients with Parkinson's disease].Rev Invest Clin. 2012; 64: 220-226
- Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease.Int J Neurosci. 2014; 124: 187-191
- Profile of idiopathic parkinson's disease in Moroccan patients.Int Arch Med. 2014; 7: 10
- Gender effect on time to levodopa-induced dyskinesias.J Neurol. 2011; 258: 2048-2053
- Classifying risk factors for dyskinesia in Parkinson's disease.Parkinsonism Relat Disord. 2010; 16: 490-497
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.Mov Disord. 2013; 28: 1064-1071
- Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.Expert Rev Neurother. 2015; 15: 1285-1297
- Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.Curr Med Res Opin. 2018; 34: 2063-2073
- Patient preference of device-based treatment of Parkinson's disease.Int J Neurosci. 2021; : 1-5
- How Parkinson's patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide survey.J Clin Neurosci. 2022; 95: 20-26
- A review of social and relational aspects of deep brain stimulation in Parkinson's disease informed by healthcare provider experiences.Parkinsons Dis 2011. 2011; 871874
- Parkinson's Patients' Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study.MDM Policy Pract. 2021; 62381468320978407
- Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.J Neurol Neurosurg Psychiatry. 2013; 84: 1273-1281
- Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson's Disease.J Mov Disord. 2015; 8: 83-91
- Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.Ann Neurol. 2009; 65 (Jr): 586-595
- EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.Mov Disord. 2019; 34: 353-365
- Patient and caregiver perceptions of the social impact of advanced Parkinson's disease and dyskinesias.J Neural Transm (Vienna). 2012; 119: 1367-1371
- Motor fluctuations and psychological distress in Parkinson's disease.Health Psychol. 2019; 38: 518-526
- Correlates of psychological distress among urban trauma-exposed adults: Influence of age and coping preferences.Psychol Trauma. 2017; 9: 85-92
- Incidence and predictors of acute psychological distress and dissociation after motor vehicle collision: a cross-sectional study.J Trauma Dissociation. 2014; 15: 527-547
- Perceived income inadequacy as a predictor of psychological distress in Alzheimer's caregivers.Psychol Aging. 2009; 24: 177-183
- Coping with disease-related stressors in Parkinson's disease.Gerontologist. 2000; 40: 53-63
- Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life.NPJ Parkinsons Dis. 2020; 6: 28
- Social Isolation, Loneliness and Health Among Older Adults.Journal of Aging and Health. 2012; 24: 1346-1363
- An overview of systematic reviews on the public health consequences of social isolation and loneliness.Public Health. 2017; 152: 157-171
- Why Social Relationships Are Important for Physical Health: A Systems Approach to Understanding and Modifying Risk and Protection.Annual Review of Psychology. 2018; 69: 437-458
- Increased risk of mortality associated with social isolation in older men: only when feeling lonely? Results from the Amsterdam Study of the Elderly (AMSTEL).Psychological Medicine. 2012; 42: 843-853
- Loneliness Matters: A Theoretical and Empirical Review of Consequences and Mechanisms.Annals of Behavioral Medicine. 2010; 40: 218-227
- The Impact of Living with Parkinson's Disease: Balancing within a Web of Needs and Demands.Parkinson's Disease. 2018; 2018: 1-8
Global Wellness Institute, What is Wellness?, https://globalwellnessinstitute.org/what-is-wellness/,
- Social cognitive theory: an agentic perspective.Annu Rev Psychol. 2001; 52: 1-26
- Are Common Sense Model constructs and self-efficacy simultaneously correlated with self-management behaviors and health outcomes: A systematic review.Health Psychol Open. 2020; 72055102919898846
- Self-management support programs for persons with Parkinson's disease: An integrative review.Patient Educ Couns. 2017; 100: 1787-1795
- Moving from physician-centered care towards patient-centered care for Parkinson's disease patients.Parkinsonism Relat Disord. 2013; 19: 923-927
- Association between patient education and health-related quality of life in patients with Parkinson's disease.Qual Life Res. 2004; 13: 81-89
- Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease.Sci Rep. 2021; 11: 4051
- Effects of Mental Flexibility and Motor Dysfunction on Cognitive Performance in Patients With Parkinson's.Disease. 2015; 2: e21087
- The Past and Possible Futures of Hope.Journal of Social and Clinical Psychology. 2000; 19: 11-28
- The metatheory of resilience and resiliency.J Clin Psychol. 2002; 58: 307-321
- Resilience training that can change the brain.Consulting Psychology Journal: Practice and Research. 2018; 70: 59
Europe WHOROf (2013) World Health Organization, p. 182.
- Examining resilience of quality of life in the face of health-related and psychosocial adversity at older ages: what is "right" about the way we age?.Gerontologist. 2010; 50: 36-47
- The roles of resilience and nonmotor symptoms in adjustment to Parkinson's disease.J Health Psychol. 2016; 21: 3004-3015
- What determines resilience in patients with Parkinson's disease?.Parkinsonism Relat Disord. 2012; 18: 174-177
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment.Mov Disord. 2021; 36: 2549-2558
- Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.Am J Psychiatry. 2011; 168: 1066-1074
- Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial.Neurology. 2020; 94: e1764-e1773
- Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches.Semin Neurol. 2022; 42: 158-167
- Digital phenotyping in Parkinson's disease: Empowering neurologists for measurement-based care.Parkinsonism Relat Disord. 2020 Nov; 80: 35-40
- Provision of Collaborative Care Model and General Behavioral Health Integration Services in Medicare.Psychiatr Serv. 2021 Jul 1; 72: 822-825https://doi.org/10.1176/appi.ps.202000265. Epub 2021 Apr 15. PMID: 33853381
- Optimizing future planning in Parkinson disease: suggestions for a comprehensive roadmap from patients and care partners.Ann Palliat Med. 2020; 9: S63-s74
- Caring for an invisible population - those with advanced Parkinson's disease.Parkinsonism Relat Disord. 2023; Jan105243
Article info
Publication history
Accepted:
February 23,
2023
Received in revised form:
February 22,
2023
Received:
January 29,
2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Published by Elsevier Inc. on behalf of American Association for Geriatric Psychiatry.
